Hubert Schefer
Impact in
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
- Dermatology top 10%
- Chemotherapy-related skin toxicity
Papers in
- Co-authors
- Thomas Cerny (2 shared papers)Martin F. Fey (2 shared papers)Daniel C. Betticher (2 shared papers)R Joss (3 shared papers)Silvia Mattmann (1 shared paper)Francesco Bertoni (1 shared paper)Michele E. G. Ghielmini (1 shared paper)Rolf Arno Stahel (1 shared paper)
- Journals
- Supportive Care in Cancer (1 paper)Journal of Clinical Oncology (1 paper)Annals of Oncology (1 paper)Cancer Imaging (1 paper)Clinical Genetics (1 paper)
- Partner nations
- SwitzerlandAustria
In The Last Decade
Hubert Schefer
12 papers receiving 355 citations
Peers
Comparison fields: 5 of 54
- Pathology and Forensic Medicine 145
- Dermatology 49
- Surgery 72
- Hepatology 12
- Clinical Biochemistry 6
Countries citing papers authored by Hubert Schefer
This map shows the geographic impact of Hubert Schefer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hubert Schefer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hubert Schefer more than expected).
Fields of papers citing papers by Hubert Schefer
This network shows the impact of papers produced by Hubert Schefer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hubert Schefer. The network helps show where Hubert Schefer may publish in the future.
Co-authors
The 25 scholars most cited alongside Hubert Schefer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 161 | |
| 2 | 2013 | 58 | |
| 3 | 2007 | 49 | |
| 4 | 1998 | 40 | |
| 5 | Comparative pharmacokinetics of oral and intravenous ifosfamide/mesna/methylene blue therapy. | 1998 | 33 |
| 6 | [Cardioprotection in chemo- and radiotherapy for malignant diseases--an echocardiographic pilot study]. | 1995 | 14 |
| 7 | 2020 | 8 | |
| 8 | A MOLECULAR-GENETIC APPROACH TO THE DIAGNOSIS OF HEREDITARY FORMS OF RETINOBLASTOMA | 1985 | 5 |
| 9 | 2009 | 5 | |
| 10 | 2013 | 3 | |
| 11 | [Current aspects and problems relating to medical ethics in oncology]. | 1998 | 1 |
| 12 | 2024 | 1 | |
| 13 | [Frequent errors in planning and clinical management of tumor therapy]. | 1990 | 0 |
About Hubert Schefer
Hubert Schefer is a scholar working on Pathology and Forensic Medicine, Family Practice, General Health Professions, Clinical Biochemistry and Emergency Medical Services, having authored 13 papers that have together received 378 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (1 paper), Ocular Oncology and Treatments (1 paper), Metabolism and Genetic Disorders (1 paper), Cancer therapeutics and mechanisms (1 paper), Ethics and bioethics in healthcare (1 paper), Testicular diseases and treatments (1 paper), Patient Safety and Medication Errors (1 paper) and Electrolyte and hormonal disorders (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (145 citations), Dermatology (49 citations), Surgery (72 citations), Hepatology (12 citations) and Clinical Biochemistry (6 citations). Hubert Schefer has collaborated with scholars based in Switzerland and Austria. Frequent co-authors include Thomas Cerny, Martin F. Fey, Daniel C. Betticher, R Joss, Silvia Mattmann, Francesco Bertoni, Michele E. G. Ghielmini, Rolf Arno Stahel, Gabriella Pichert and Shu‐Fang Hsu Schmitz. Their work appears in journals such as Supportive Care in Cancer, Journal of Clinical Oncology, Annals of Oncology, Cancer Imaging and Clinical Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.